ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Highlights of the May 2021 Pharmacovigilance Risk Assessment Committee (PRAC) meeting
May 11, 2021In its May meeting, the EMA’s drug safety committee (PRAC) concluded two safety signal reviews for COVID-19 vaccines and began several more. -
Inactivated COVID-19 vaccine candidate enters comparative immunogenicity trial
April 26, 2021The Phase III trial aims to demonstrate that Valneva’s VLA2001 is more immunogenic than AstraZeneca’s conditionally approved COVID-19 vaccine, Vaxzevria. -
Highlights of the EMA’s drug safety committee April meeting
April 14, 2021In the April meeting the Pharmacovigilance Risk Assessment Committee began two new reviews of adverse events that could be caused by COVID-19 vaccines.
Pharma Sources Insight January 2025
